A novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo.

MLA

Yifei Huang, et al. “A Novel Hydrolysis-Resistant Lipophilic Folate Derivative Enables Stable Delivery of Targeted Liposomes in Vivo.” International Journal of Nanomedicine, vol. 9, Sept. 2014, pp. 4581–95. EBSCOhost, https://doi.org/10.2147/IJN.S69115.

APA

Yifei Huang, Tan Yang, Wendian Zhang, Yao Lu, Peng Ye, Guang Yang, Bin Li, Shibo Qi, Yong Liu, Xingxing He, Lee, R. J., Chuanrui Xu, & Guangya Xiang. (2014). A novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo. International Journal of Nanomedicine, 9, 4581–4595. https://doi.org/10.2147/IJN.S69115

Chicago

Yifei Huang, Tan Yang, Wendian Zhang, Yao Lu, Peng Ye, Guang Yang, Bin Li, et al. 2014. “A Novel Hydrolysis-Resistant Lipophilic Folate Derivative Enables Stable Delivery of Targeted Liposomes in Vivo.” International Journal of Nanomedicine 9 (September): 4581–95. doi:10.2147/IJN.S69115.